 | Up a level |
Dal Pra, A.; Ghadjar, P.; Hayoz, S.; Spratt, D.E.; Liu, V.Y.; Todorovic, T.; Davicioni, E.; Huang, H.C.; Schär, C.; Hölscher, T.; Gut, P.; Polat, B.; Hildebrandt, G.; Mueller, A.C.; Plasswilm, L.; Thalmann, G.; Zwahlen, D.R.; Aebersold, D.M. (2021). Performance of a Genomic Classifier (GC) Within a Phase 3 Randomized Trial of Dose Escalated Salvage Radiotherapy (SRT) After Radical Prostatectomy (RP). International journal of radiation oncology, biology, physics, 111(3, Suppl. 1), S49-S50. Elsevier 10.1016/j.ijrobp.2021.07.132
Krentel, A. F.; Singer, F.; Gibb, E.; Yang, L.; Davicioni, E.; Kruithof-de Julio, M.; Seiler, R. (15 March 2019). The genomic landscape of muscle-invasive bladder cancer enables a personalized in silico drug discovery. European Urology Supplements, 18(1), e591-e591. Elsevier 10.1016/S1569-9056(19)30438-5
Genitsch, V.; Kollár, A.; Blarer, J.; Vandekerkhove, G.; Furrer, M.; Krentel, A.; Gibb, E.; Davicioni, E.; Wyatt, A.; Seiler, R. (15 March 2019). Molecular decoding of sarcomatoid variant of muscle-invasive bladder cancer might reveal treatment strategies. European Urology Supplements, 18(1), e1449-e1449. Elsevier 10.1016/S1569-9056(19)31044-9
Krentel, F.; Singer, F.; Gibb, E. A.; Liu, Y.; Davicioni, E.; Kruithof-de Julio, M.; Seiler, R. (2019). Medikamentöse Tumortherapie für das muskelinvasive Blasenkarzinom basierend auf dessen genetischen Profil. Der Urologe, 58(Suppl 1), S100-S100. Springer
